India Glycols Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
1112.80 -29.85 (-2.61%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1108.95
Today’s High
1154.95
52 Week Low
685
52 Week High
1545
1110.20 -32.80 (-2.87%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1105.5
Today’s High
1141.85
52 Week Low
678.55
52 Week High
1548.95
Key Metrics
- Market Cap (In Cr) 3538.9
- Beta 1.17
- Div. Yield (%) 0.7
- P/B 1.73
- TTM P/E 19.6
- Peg Ratio 1.1
- Sector P/E 24.11
- D/E 0.77
- Open Price 1154.95
- Prev Close 1142.65
India Glycols Analysis
Price Analysis
-
1 Week-1.8%
-
3 Months-9.65%
-
6 Month44.63%
-
YTD48.84%
-
1 Year59.35%
Risk Meter
- 51% Low risk
- 51% Moderate risk
- 51% Balanced Risk
- 51% High risk
- 51% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 0
- 0
- 0
- 0
- Hold
- 0
- 0
- 0
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 1
- 1
- 1
- 1
India Glycols News
Muhurat Trading 2024: Hensex Securities recommends nine stocks to buy today
6 min read . 01 Nov 2024National Aluminium Company, India Glycols & others hit 52 week high today ; Do you own any?
3 min read . 14 Oct 2024India Glycols Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 7921.54
- Selling/ General/ Admin Expenses Total
- 103.37
- Depreciation/ Amortization
- 100.77
- Other Operating Expenses Total
- 310.97
- Total Operating Expense
- 7619.95
- Operating Income
- 301.59
- Net Income Before Taxes
- 223.31
- Net Income
- 172.99
- Diluted Normalized EPS
- 55.87
- Period
- 2024
- Total Assets
- 5616.8
- Total Liabilities
- 3565.78
- Total Equity
- 2051.02
- Tangible Book Valueper Share Common Eq
- 661.92
- Period
- 2024
- Cashfrom Operating Activities
- 438.51
- Cashfrom Investing Activities
- -503.45
- Cashfrom Financing Activities
- 89.93
- Net Changein Cash
- 24.99
- Period
- 2023
- Total Revenue
- 6641.64
- Selling/ General/ Admin Expenses Total
- 274.09
- Depreciation/ Amortization
- 93.82
- Other Operating Expenses Total
- -0.56
- Total Operating Expense
- 6379.1
- Operating Income
- 262.54
- Net Income Before Taxes
- 165.01
- Net Income
- 125.08
- Diluted Normalized EPS
- 32.24
- Period
- 2023
- Total Assets
- 4858.33
- Total Liabilities
- 2956.91
- Total Equity
- 1901.42
- Tangible Book Valueper Share Common Eq
- 613.51
- Period
- 2023
- Cashfrom Operating Activities
- 325.71
- Cashfrom Investing Activities
- -330.28
- Cashfrom Financing Activities
- -0.51
- Net Changein Cash
- -5.07
- Period
- 2022
- Total Revenue
- 6601.41
- Selling/ General/ Admin Expenses Total
- 301.24
- Depreciation/ Amortization
- 80.15
- Other Operating Expenses Total
- -0.43
- Total Operating Expense
- 6193.09
- Operating Income
- 408.32
- Net Income Before Taxes
- 369.01
- Net Income
- 339.85
- Diluted Normalized EPS
- 42.63
- Period
- 2022
- Total Assets
- 4630.67
- Total Liabilities
- 2838.77
- Total Equity
- 1791.9
- Tangible Book Valueper Share Common Eq
- 578.22
- Period
- 2022
- Cashfrom Operating Activities
- 116.04
- Cashfrom Investing Activities
- 76.45
- Cashfrom Financing Activities
- -188.83
- Net Changein Cash
- 3.66
- Period
- 2021
- Total Revenue
- 5427.47
- Selling/ General/ Admin Expenses Total
- 277.53
- Depreciation/ Amortization
- 79.98
- Other Operating Expenses Total
- -0.38
- Total Operating Expense
- 5224.13
- Operating Income
- 203.34
- Net Income Before Taxes
- 120.48
- Net Income
- 131.61
- Diluted Normalized EPS
- 35.29
- Period
- 2021
- Total Assets
- 4119.24
- Total Liabilities
- 2950.72
- Total Equity
- 1168.52
- Tangible Book Valueper Share Common Eq
- 376.81
- Period
- 2021
- Cashfrom Operating Activities
- 137.33
- Cashfrom Investing Activities
- -148.33
- Cashfrom Financing Activities
- 10.75
- Net Changein Cash
- -0.26
- Period
- 2020
- Total Revenue
- 5217.1
- Selling/ General/ Admin Expenses Total
- 280.25
- Depreciation/ Amortization
- 77.39
- Other Operating Expenses Total
- -0.2
- Total Operating Expense
- 4977.82
- Operating Income
- 239.28
- Net Income Before Taxes
- 112.72
- Net Income
- 114.66
- Diluted Normalized EPS
- 24.16
- Period
- 2020
- Total Assets
- 4086.23
- Total Liabilities
- 3052.37
- Total Equity
- 1033.87
- Tangible Book Valueper Share Common Eq
- 333.26
- Period
- 2020
- Cashfrom Operating Activities
- 343.26
- Cashfrom Investing Activities
- -150.91
- Cashfrom Financing Activities
- -215.67
- Net Changein Cash
- -23.32
- Period
- 2019
- Total Revenue
- 5117.4
- Selling/ General/ Admin Expenses Total
- 310.71
- Depreciation/ Amortization
- 76.14
- Other Operating Expenses Total
- 19.89
- Total Operating Expense
- 4739.39
- Operating Income
- 378.02
- Net Income Before Taxes
- 213.12
- Net Income
- 132.61
- Diluted Normalized EPS
- 42.84
- Period
- 2019
- Total Assets
- 3784.32
- Total Liabilities
- 2821.7
- Total Equity
- 962.63
- Tangible Book Valueper Share Common Eq
- 310.88
- Period
- 2019
- Cashfrom Operating Activities
- 147.07
- Cashfrom Investing Activities
- -128.14
- Cashfrom Financing Activities
- 3.01
- Net Changein Cash
- 21.94
- Period
- 2018
- Total Revenue
- 4162
- Selling/ General/ Admin Expenses Total
- 306.37
- Depreciation/ Amortization
- 73.07
- Other Operating Expenses Total
- -0.31
- Total Operating Expense
- 3911.15
- Operating Income
- 250.85
- Net Income Before Taxes
- 147.16
- Net Income
- 96.53
- Diluted Normalized EPS
- 31.12
- Period
- 2018
- Total Assets
- 3421.49
- Total Liabilities
- 2576.35
- Total Equity
- 845.14
- Tangible Book Valueper Share Common Eq
- 272.96
- Period
- 2018
- Cashfrom Operating Activities
- 501.74
- Cashfrom Investing Activities
- -102.81
- Cashfrom Financing Activities
- -399.4
- Net Changein Cash
- -0.47
- Period
- 2024-09-30
- Total Revenue
- 2143.71
- Selling/ General/ Admin Expenses Total
- 30.28
- Depreciation/ Amortization
- 27.57
- Other Operating Expenses Total
- 98.1
- Total Operating Expense
- 2055.5
- Operating Income
- 88.21
- Net Income Before Taxes
- 63.46
- Net Income
- 49.71
- Diluted Normalized EPS
- 16.06
- Period
- 2024-09-30
- Total Assets
- 5551.85
- Total Liabilities
- 3415.65
- Total Equity
- 2136.2
- Tangible Book Valueper Share Common Eq
- 689.47
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 18.85
- Cashfrom Investing Activities
- -247.67
- Cashfrom Financing Activities
- 204.54
- Net Changein Cash
- -24.28
- Period
- 2024-06-30
- Total Revenue
- 2039.08
- Selling/ General/ Admin Expenses Total
- 29.94
- Depreciation/ Amortization
- 26.04
- Other Operating Expenses Total
- 83.62
- Total Operating Expense
- 1960.54
- Operating Income
- 78.54
- Net Income Before Taxes
- 55.6
- Net Income
- 42.21
- Diluted Normalized EPS
- 13.63
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 2039.08
- Selling/ General/ Admin Expenses Total
- 29.94
- Depreciation/ Amortization
- 26.04
- Other Operating Expenses Total
- 83.62
- Total Operating Expense
- 1960.54
- Operating Income
- 78.54
- Net Income Before Taxes
- 55.6
- Net Income
- 42.21
- Diluted Normalized EPS
- 13.63
- Period
- 2024-03-31
- Total Assets
- 5616.8
- Total Liabilities
- 3565.78
- Total Equity
- 2051.02
- Tangible Book Valueper Share Common Eq
- 661.92
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 438.51
- Cashfrom Investing Activities
- -503.45
- Cashfrom Financing Activities
- 89.93
- Net Changein Cash
- 24.99
- Period
- 2023-12-31
- Total Revenue
- 2119.19
- Selling/ General/ Admin Expenses Total
- 27.44
- Depreciation/ Amortization
- 26.24
- Other Operating Expenses Total
- 78.42
- Total Operating Expense
- 2043.17
- Operating Income
- 76.02
- Net Income Before Taxes
- 53.89
- Net Income
- 41.63
- Diluted Normalized EPS
- 13.45
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 1869.88
- Selling/ General/ Admin Expenses Total
- 23.18
- Depreciation/ Amortization
- 27.96
- Other Operating Expenses Total
- 75.8
- Total Operating Expense
- 1802.33
- Operating Income
- 67.55
- Net Income Before Taxes
- 50.1
- Net Income
- 38.01
- Diluted Normalized EPS
- 12.27
- Period
- 2023-09-30
- Total Assets
- 5119.16
- Total Liabilities
- 3152.38
- Total Equity
- 1966.78
- Tangible Book Valueper Share Common Eq
- 634.67
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 171.61
- Cashfrom Investing Activities
- -72.65
- Cashfrom Financing Activities
- -98.27
- Net Changein Cash
- 0.69
- Period
- 2023-06-30
- Total Revenue
- 1893.64
- Selling/ General/ Admin Expenses Total
- 22.81
- Depreciation/ Amortization
- 20.53
- Other Operating Expenses Total
- 73.38
- Total Operating Expense
- 1814.16
- Operating Income
- 79.48
- Net Income Before Taxes
- 63.72
- Net Income
- 51.14
- Diluted Normalized EPS
- 16.52
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 1615.65
- Selling/ General/ Admin Expenses Total
- 26.26
- Depreciation/ Amortization
- 29.72
- Other Operating Expenses Total
- 70.38
- Total Operating Expense
- 1549.36
- Operating Income
- 66.29
- Net Income Before Taxes
- 45.65
- Net Income
- 40.32
- Diluted Normalized EPS
- 13.02
- Period
- 2023-03-31
- Total Assets
- 4858.33
- Total Liabilities
- 2956.91
- Total Equity
- 1901.42
- Tangible Book Valueper Share Common Eq
- 613.51
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 325.71
- Cashfrom Investing Activities
- -330.28
- Cashfrom Financing Activities
- -0.51
- Net Changein Cash
- -5.07
- Period
- 2022-12-31
- Total Revenue
- 1524.42
- Selling/ General/ Admin Expenses Total
- 23.02
- Depreciation/ Amortization
- 21.44
- Other Operating Expenses Total
- 64.91
- Total Operating Expense
- 1448.58
- Operating Income
- 75.84
- Net Income Before Taxes
- 53.26
- Net Income
- 30.73
- Diluted Normalized EPS
- 2.26
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
India Glycols Technical
Moving Average
SMA
- 5 Day1139.8
- 10 Day1196.66
- 20 Day1208.59
- 50 Day1276.1
- 100 Day1201.61
- 300 Day1017.14
India Glycols Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- BHAGIRADHA CHEMICALS & INDUSTRI
- 312.25
- -14.8
- -4.53
- 448
- 116.51
- 3249.11
- Fineotex Chemical
- 324.25
- -10.45
- -3.12
- 458
- 305.2
- 3591.55
- India Glycols
- 1112.8
- -29.85
- -2.61
- 1545
- 685
- 3445.4
- Savita Oil Technologies
- 478.6
- -7.4
- -1.52
- 655
- 315
- 3307.15
- Thirumalai Chemicals
- 313.85
- -9.05
- -2.8
- 362.8
- 189
- 3214.71
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- BHAGIRADHA CHEMICALS & INDUSTRI
- 202.57
- 8.18
- 12.14
- 6.75
- Fineotex Chemical
- 30.92
- 8.29
- 24.67
- 17.46
- India Glycols
- 20.82
- 1.73
- 10.97
- 2.6
- Savita Oil Technologies
- 17.1
- 2.08
- 17.05
- 7.05
- Thirumalai Chemicals
- -
- 2.89
- 10.23
- 5.64
India Glycols Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-Nov-24
- Quarterly Results
- 29-Jul-24
- Quarterly Results
- 28-May-24
- Audited Results & Final Dividend
- 02-Feb-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 24-May-23
- Audited Results & Final Dividend
- 08-Feb-23
- Quarterly Results
- 10-Nov-22
- Quarterly Results
- 09-Aug-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Aug-24
- 31-Jul-24
- AGM
- 27-Mar-24
- 23-Feb-24
- POM
- 27-Dec-23
- 24-Nov-23
- POM
- 12-Sept-23
- 17-Aug-23
- AGM
- 27-Apr-21
- 26-Mar-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- -
- 21-Aug-24
- 8
- 24-May-23
- -
- 05-Sept-23
- 7.5
- 25-Jun-21
- -
- 16-Sept-21
- 6